Also known as Mechano Growth Factor · IGF-1Ec · IGF-1 Ec
A splice variant of IGF-1 expressed after muscle damage; studied for satellite-cell activation.
MGF is the IGF-1Ec splice variant — produced locally in muscle after mechanical overload or injury. Its distinct C-terminal E-peptide is studied for activating satellite cells, upstream of IGF-1’s hypertrophic role.
Mechano growth factor (MGF) is a splice variant of IGF-1, also called IGF-1Ec. A 49-base-pair insert in exon 5 introduces a reading-frame shift, producing a distinct C-terminal peptide (the "E-domain") not found in the main circulating IGF-1 isoform.
MGF is expressed rapidly and locally in muscle after mechanical overload or damage — the experimental basis was established by Geoffrey Goldspink and colleagues (UCL) beginning in the late 1990s. Its proposed role is to begin repair by activating satellite cells before differentiation, complementing the longer-acting hypertrophic signal of IGF-1 itself. It is a research compound, not FDA-approved.
Local IGF-1 splice variant; the E-peptide activates muscle satellite (stem) cells, complementing IGF-1-receptor signaling.
Behind every vial of MGF (Mechano Growth Factor) is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how MGF (Mechano Growth Factor), specifically, is brought into being.
MGF (Mechano Growth Factor) begins not as a powder but as a specification. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
MGF (Mechano Growth Factor) is assembled by solid-phase peptide synthesis — the chain grows one protected residue at a time on resin, and what you fail to build cleanly here you pay to remove later.
The crude mixture — MGF (Mechano Growth Factor) plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one.
A real batch of MGF (Mechano Growth Factor) proves itself: identity confirmed by mass spectrometry, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of MGF (Mechano Growth Factor) — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
Producing MGF (Mechano Growth Factor) to a genuine purity spec means solid-phase synthesis, preparative HPLC purification, and batch quality control — none of it cheap, and none of it something you can verify by eye.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
Recent clinical trials and publications mentioning Mechano Growth Factor, pulled automatically from ClinicalTrials.gov and PubMed and refreshed daily. Listings are unfiltered search results, not curated endorsements.
MGF (mechano growth factor) is a splice variant of IGF-1 (IGF-1Ec) produced locally in muscle after damage. Its distinct E-peptide is studied for activating satellite cells.
MGF is a splice variant with a unique C-terminal peptide, expressed locally after mechanical stress. Where standard IGF-1 sustains hypertrophy systemically, MGF is studied for initiating repair by activating satellite cells.
MGF is local and transient (satellite-cell activation); IGF-1 LR3 is systemic and long-acting (hypertrophy). They are generally studied in sequence rather than together.
No. It is a research compound, not FDA-approved, and is prohibited in sport. This page is a research and educational reference.
Recombinant 191-amino-acid human growth hormone — a folded protein biologic identical in sequence to pituitary GH, not a synthetic research peptide.
ViewThe downstream effector of growth hormone — a 70-amino-acid recombinant protein, structurally a cousin of proinsulin, that carries out most of GH’s growth signal.
ViewA long-acting modified IGF-1 analog with reduced IGFBP binding and prolonged systemic activity.
View